Roche's Dx Sales Increase 3 Percent in Q1

Roche Diagnostics' sales were driven by RT-PCR platforms, blood screening products, and DNA sequencing and microarray products in its applied science business.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories